Table 1.

Current rAAV-mediated FIX gene transfer clinical trials

SponsorInterventionGene productCapsidManufacturing platformGenome configurationHighest-dose cohort (vg/kg)Required steroidsMean sustained FIX:C (% of normal)IdentifierStatusReferences
UCL/St. Jude’s scAAV2/8-LP1-hFIXco FIX rAAV8 Mammalian sc 2 × 1012 4/6 5.1 NCT00979238 Recruiting 1,2 
Shire AskBio FIX-Padua rAAV8 Mammalian sc 3 × 1012 2/3 NCT01687608 Active, not recruiting 20 
Spark Therapeutics/Pfizer SPK-9001 FIX-Padua rAAV-Spark100 Mammalian ss 5 × 1011 2/10 33 NCT02484092 Recruiting 22 
uniQure AMT-060 FIX rAAVS Insect sc 2 × 1013 2/5 6.9 NCT02396342 Active, not recruiting 23 
Dimension Therapeutics DTX101 FIX rAAVrh-10 Mammalian sc 5 × 1012 3/3 6.7 NCT02971969 Recruiting* 36 
Sangamo Biosciences SB-FIX Zn finger–FIX rAAV6 Insect     NCT02695160 Recruiting N/A 
Freeline Therapeutics FLT-180 FIX-Padua rAAV-engineersd Mammalian       N/A 
SponsorInterventionGene productCapsidManufacturing platformGenome configurationHighest-dose cohort (vg/kg)Required steroidsMean sustained FIX:C (% of normal)IdentifierStatusReferences
UCL/St. Jude’s scAAV2/8-LP1-hFIXco FIX rAAV8 Mammalian sc 2 × 1012 4/6 5.1 NCT00979238 Recruiting 1,2 
Shire AskBio FIX-Padua rAAV8 Mammalian sc 3 × 1012 2/3 NCT01687608 Active, not recruiting 20 
Spark Therapeutics/Pfizer SPK-9001 FIX-Padua rAAV-Spark100 Mammalian ss 5 × 1011 2/10 33 NCT02484092 Recruiting 22 
uniQure AMT-060 FIX rAAVS Insect sc 2 × 1013 2/5 6.9 NCT02396342 Active, not recruiting 23 
Dimension Therapeutics DTX101 FIX rAAVrh-10 Mammalian sc 5 × 1012 3/3 6.7 NCT02971969 Recruiting* 36 
Sangamo Biosciences SB-FIX Zn finger–FIX rAAV6 Insect     NCT02695160 Recruiting N/A 
Freeline Therapeutics FLT-180 FIX-Padua rAAV-engineersd Mammalian       N/A 

N/A, not applicable; sc, self-complementary; ss, single stranded; UCL, University College London.

*Sponsor’s press release indicates the trial is no longer recruiting.

or Create an Account

Close Modal
Close Modal